A patient with stage 3 chronic kidney disease and polycystic kidney disease experiences poorly controlled hypertension despite being on antihypertensive therapy. Which nursing intervention should be prioritized to address the progression of renal impairment in this patient?

B) Instruct the patient to monitor blood pressure daily and report consistent readings above target range.

A) Encourage the patient to increase fluid intake to enhance kidney function.

B) Instruct the patient to monitor blood pressure daily and report consistent readings above target range.

C) Advise the patient to continue using ibuprofen for pain management as needed.

D) Recommend a high-protein diet to support overall health.

A patient with stage 3 chronic kidney disease (CKD) and polycystic kidney disease has been using ibuprofen regularly for pain management. Which of the following nursing interventions is most appropriate to address the patient's pain management and prevent further renal damage?

B) Educate the patient on the risks of NSAIDs and recommend acetaminophen as an alternative pain reliever.

A) Continue the current ibuprofen regimen as it effectively manages the patient's pain.

B) Educate the patient on the risks of NSAIDs and recommend acetaminophen as an alternative pain reliever.

C) Suggest an increase in ibuprofen dosage to manage the pain more effectively.

D) Refer the patient to a pain management specialist for opioid therapy.

A patient with stage 3 chronic kidney disease (CKD) presents with elevated blood pressure, increased fatigue, lower extremity swelling, and hyperkalemia. Which nursing action is the most appropriate to address the patient's current condition?

B) Educate the patient on avoiding high-potassium foods to manage hyperkalemia.

A) Encourage the patient to increase fluid intake to improve renal perfusion.

B) Educate the patient on avoiding high-potassium foods to manage hyperkalemia.

C) Recommend the patient to engage in high-intensity exercise to lower blood pressure.

D) Suggest reducing antihypertensive medication to prevent further renal impairment.

A patient with stage 3 chronic kidney disease presents with elevated blood pressure, increased serum creatinine, hyperkalemia, and reports of fatigue and swelling in the lower extremities. Which nursing intervention is the priority in managing this patient's condition?

B) Educate the patient on adhering to a low-potassium diet to prevent cardiac complications.

A) Encourage the patient to increase fluid intake to improve renal perfusion.

B) Educate the patient on adhering to a low-potassium diet to prevent cardiac complications.

C) Advise the patient to restrict protein intake to reduce the burden on the kidneys.

D) Recommend the patient to perform regular physical exercise to lower blood pressure.

A patient with chronic kidney disease (CKD) presents with acute kidney injury (AKI) and hyperkalemia. Which nursing intervention is the priority to prevent potential cardiac complications?

C) Monitor the patient's cardiac rhythm continuously.

A) Administer a potassium-binding resin as prescribed.

B) Encourage the patient to increase fluid intake to flush out potassium.

C) Monitor the patient's cardiac rhythm continuously.

D) Educate the patient on reducing dietary potassium intake.

A patient with chronic kidney disease now presents with acute kidney injury, hypertension, and hyperkalemia. The healthcare team is considering implementing diuretic therapy. Which nursing action is most appropriate to address the patient's current condition?

B) Educate the patient on reducing dietary potassium intake.

A) Administer a potassium-sparing diuretic to manage fluid retention.

B) Educate the patient on reducing dietary potassium intake.

C) Encourage the patient to increase fluid intake to promote renal perfusion.

D) Hold all antihypertensive medications until potassium levels normalize.

A patient recently started on diuretic therapy for hypertension is experiencing increased fatigue, mild peripheral edema, and episodes of dizziness when standing. Recent labs show a serum creatinine of 3.0 mg/dL, GFR of 30 mL/min/1.73 m², and serum potassium of 5.5 mEq/L. Which nursing intervention is most appropriate to address her current symptoms and lab findings?

B) Monitor the patient’s blood pressure in different positions to assess for orthostatic changes and collaborate with the healthcare provider on medication adjustments.

A) Educate the patient on increasing fluid intake to manage edema and dizziness.

B) Monitor the patient’s blood pressure in different positions to assess for orthostatic changes and collaborate with the healthcare provider on medication adjustments.

C) Encourage the patient to consume a high-protein diet to improve kidney function.

D) Instruct the patient to reduce potassium-rich foods to help manage hyperkalemia.

A patient with chronic kidney disease is experiencing increased fatigue, mild peripheral edema, and dizziness upon standing after starting diuretic therapy. Her blood pressure remains elevated, and recent lab results indicate a serum creatinine of 3.0 mg/dL and a GFR of 30 mL/min/1.73 m². What is the nurse's priority intervention to address these findings?

D) Suggest the provider consider switching to an antihypertensive that does not worsen hyperkalemia.

A) Educate the patient on a low-potassium diet to manage hyperkalemia.

B) Recommend increasing the dose of diuretics to reduce fluid overload.

C) Advise the patient to rise slowly from sitting to standing positions.

D) Suggest the provider consider switching to an antihypertensive that does not worsen hyperkalemia.

A patient with chronic kidney disease and hypertension is experiencing nocturia, fatigue, and increased proteinuria despite being on an ARB. Which intervention should the nurse prioritize to address the patient's condition?

C) Collaborate with the healthcare team to discuss potential renal replacement therapy

A) Increase the dosage of the ARB to further control blood pressure

B) Educate the patient on the importance of fluid restriction to manage nocturia

C) Collaborate with the healthcare team to discuss potential renal replacement therapy

D) Advise the patient to increase potassium intake to balance electrolyte levels

A patient with hypertension, renal impairment, and mild hyperkalemia is being managed with an angiotensin receptor blocker (ARB). She presents with persistent fatigue, mild peripheral edema, and nocturia. Her lab results show stabilized potassium levels but increased proteinuria and BUN. What is the most appropriate next step in managing this patient's condition?

B) Add a diuretic to the treatment regimen

A) Increase the dose of the current ARB

B) Add a diuretic to the treatment regimen

C) Recommend dietary potassium restriction

D) Initiate a discussion on renal replacement therapy

polycystic kidney disease undiagnosed - Nursing Case Study

Pathophysiology

• Primary mechanism: Genetic mutation in PKD1 or PKD2 genes leads to abnormal polycystin proteins, disrupting renal tubular cell function and causing fluid-filled cysts to form in the kidneys.

• Secondary mechanism: Cyst growth compresses surrounding renal tissue, reducing blood flow and promoting inflammation and fibrosis, which ultimately diminishes kidney function.

• Key complication: Progressive renal damage can lead to chronic kidney disease (CKD), increasing the risk of hypertension and renal failure, necessitating dialysis or transplantation.

Patient Profile

Demographics:

34-year-old female, office administrator

History:

• Key past medical history: Hypertension diagnosed 3 years ago, recurrent urinary tract infections

• Current medications: Lisinopril 10 mg daily, occasional Ibuprofen for headaches

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Persistent flank pain and increasing fatigue

• Key symptoms: Abdominal discomfort, elevated blood pressure, occasional blood in urine, swelling in the lower extremities

• Vital signs: Blood pressure 150/95 mmHg, heart rate 88 bpm, respiratory rate 18 breaths per minute, temperature 98.6°F, oxygen saturation 98% on room air

Section 1

During her follow-up appointment, the patient undergoes a series of diagnostic tests to further evaluate her persistent symptoms and assess the status of her kidney function. Laboratory results reveal elevated serum creatinine of 2.1 mg/dL and a decreased glomerular filtration rate (GFR) of 45 mL/min/1.73 m², indicating stage 3 chronic kidney disease. Urinalysis shows hematuria and mild proteinuria, consistent with previous reports of blood in the urine. An abdominal ultrasound confirms the presence of bilateral renal cysts, some of which have increased in size since her last imaging study, exerting pressure on the surrounding renal tissue.

These findings suggest a progression of polycystic kidney disease, complicating the patient's clinical picture. The increase in serum creatinine and reduced GFR highlight the diminished filtering capacity of the kidneys, necessitating adjustments in her current management plan. Her blood pressure, which remains elevated despite antihypertensive therapy, is a significant concern, as poorly controlled hypertension can further accelerate renal damage. A referral to a nephrologist is arranged to explore potential modifications in her treatment regimen, including possible adjustments to her antihypertensive medication and the initiation of a renal-protective diet.

The clinical team also considers the implications of her frequent use of ibuprofen, which can exacerbate renal impairment. Educating the patient on the risks of non-steroidal anti-inflammatory drugs (NSAIDs) and exploring alternative pain management strategies becomes a priority. The patient is counseled on lifestyle modifications, including dietary changes and blood pressure monitoring, to help slow disease progression. These steps are critical in managing her polycystic kidney disease and preventing further complications, guiding the next phase of her care plan.

Section 2

As the patient returns for her subsequent follow-up appointment, the clinical team conducts a comprehensive assessment to evaluate her response to the changes in her management plan. Despite the initiation of a renal-protective diet and adjustments to her antihypertensive therapy, her blood pressure remains elevated at 152/92 mmHg. Notably, she reports experiencing increased fatigue and occasional swelling in her lower extremities, which raises concerns about potential fluid retention and worsening renal function.

Further laboratory tests reveal a slight increase in serum creatinine to 2.3 mg/dL, indicating continued decline in kidney function. Her GFR has decreased to 40 mL/min/1.73 m², consistent with the progression of stage 3 chronic kidney disease. Electrolyte imbalances are evident, with a serum potassium level of 5.7 mEq/L, which necessitates immediate attention to prevent cardiac complications. Urinalysis shows persistent hematuria and a slight increase in proteinuria, suggesting ongoing damage to the renal parenchyma.

These findings prompt the nephrologist to consider more aggressive measures to control her blood pressure and manage her hyperkalemia. The patient is educated on the importance of adhering strictly to her low-potassium diet and is advised to avoid potassium-rich foods. The clinical team also discusses the potential need for a different class of antihypertensive medication that could offer better control of her blood pressure without exacerbating her renal impairment. The patient is scheduled for closer monitoring, with more frequent follow-up appointments to closely track her renal function and electrolyte levels. This strategy aims to stabilize her condition and mitigate the risk of further complications, as her clinical picture becomes increasingly complex.

Section 3

The patient returns for another follow-up appointment two weeks later, and the clinical team notes some concerning developments. Her vital signs reveal a blood pressure of 158/96 mmHg, indicating further difficulty in achieving adequate control despite recent medication adjustments. Additionally, she now reports experiencing mild shortness of breath and a noticeable decrease in her urine output, which prompts the healthcare providers to conduct a more detailed evaluation of her fluid status and renal function.

New laboratory results show a further increase in serum creatinine to 2.6 mg/dL, with her GFR declining to 35 mL/min/1.73 m², suggesting a quickening pace of renal deterioration. Her serum potassium remains elevated at 5.9 mEq/L, raising the urgency to address hyperkalemia more aggressively to avert potential cardiac events. The urinalysis continues to display hematuria and proteinuria, reinforcing concerns about sustained renal injury. In light of these findings, the nephrologist suspects that the patient's condition is complicated by an emerging acute kidney injury superimposed on her chronic kidney disease, possibly precipitated by volume overload or medication side effects.

In response, the clinical team deliberates on the implementation of diuretic therapy to manage her fluid retention and alleviate her hypertension, while carefully balancing the risk of exacerbating her kidney function decline. They also consider modifying her antihypertensive regimen to incorporate medications less likely to contribute to hyperkalemia. The patient is counseled on the importance of strict dietary adherence and is advised to monitor her symptoms closely. The team emphasizes the need for immediate medical attention if she experiences any chest pain, palpitations, or sudden changes in her condition. These measures aim to stabilize her current status and prevent further complications, setting the stage for closer observation and potential escalation of care if her clinical situation does not improve.

Section 4

As the patient continues under close observation, the clinical team notes a change in her status during her next follow-up visit. Despite the recent initiation of diuretic therapy, she reports increased fatigue and has developed mild peripheral edema. Her blood pressure remains elevated at 154/92 mmHg, indicating only marginal improvement. In addition to these symptoms, she now experiences occasional episodes of dizziness, particularly when standing up, suggesting possible orthostatic hypotension as a side effect of her new medication regimen.

New diagnostic results reveal a further decline in her kidney function, with her serum creatinine level rising to 3.0 mg/dL and a GFR decrease to 30 mL/min/1.73 m². Her serum potassium has slightly improved to 5.5 mEq/L, yet it remains a concern for ongoing management. Repeat urinalysis shows persistent hematuria and proteinuria, confirming sustained renal injury. The team also notes a slight increase in her BUN to 45 mg/dL, highlighting the need for reassessment of her dietary protein intake and further adjustments to her medication plan to optimize her renal and cardiovascular health.

These developments prompt the healthcare providers to reevaluate her treatment strategy. They consider transitioning her to a different class of antihypertensive agents that might better control her blood pressure without exacerbating her hyperkalemia. Additionally, the team discusses the potential need for more aggressive diuretic therapy to address her fluid overload while ensuring her electrolyte balance is carefully monitored. The patient is educated on recognizing signs of worsening renal function and instructed to maintain regular follow-up visits for ongoing monitoring. These steps aim to stabilize her condition and prevent further deterioration, setting the stage for potential referral to a specialist for consideration of advanced renal replacement therapies if her kidney function continues to decline.

Section 5

As the patient's clinical journey unfolds, the team decides to initiate a transition to an angiotensin receptor blocker (ARB) to better manage her hypertension while minimizing the risk of hyperkalemia. During her subsequent follow-up visit, she reports some improvement in her dizziness, but still experiences significant fatigue and persistent mild peripheral edema. Her blood pressure now reads 148/88 mmHg, suggesting a slight improvement, yet not achieving optimal control. The evaluation of her lab results presents a mixed picture: her serum creatinine has stabilized at 3.2 mg/dL, and her GFR remains at 30 mL/min/1.73 m². However, her BUN has increased slightly to 48 mg/dL, indicating ongoing renal impairment. Her potassium level has stabilized at 5.3 mEq/L, a modest yet reassuring development.

The team's clinical reasoning focuses on the complex interplay between managing her hypertension, preventing further renal function decline, and addressing her electrolyte imbalances. They intensify their educational efforts, emphasizing the importance of dietary modifications, including reduced sodium and protein intake, to support her renal health. The patient is counseled on the critical nature of medication adherence and warned about the potential signs of worsening renal function, such as increased fatigue, persistent edema, or changes in urine output.

Despite these interventions, the patient's condition evolves, presenting new challenges. She begins to experience nocturia, disrupting her sleep and contributing to her daytime fatigue. Her urinalysis shows an increase in proteinuria, suggesting progressive renal damage. With these developments, the healthcare team considers the need for more aggressive management strategies, including possibly initiating discussions about future renal replacement therapies. This evolving situation underscores the importance of a multidisciplinary approach, incorporating nephrology consultation to explore advanced treatment options and ensure comprehensive care planning for the patient's long-term health stability.